Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

Distress in the Pediatric Oncology Setting: Intervention Versus Natural Adaptation

ClinicalTrials.gov ID: NCT04409301

Public ClinicalTrials.gov record NCT04409301. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 12, 2026, 8:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Distress in the Pediatric Oncology Setting: Intervention Versus Natural Adaptation - A Multi-Center Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Children with cancer undergo many procedures as part of their treatment, and are often hospitalized or have frequent clinic visits, which can be distressing. Using robots or toys may be promising interventions as they provide elements of distraction therapy to children undergoing stressful and painful medical procedures. The purpose of this study is to see whether the use of a robotic toy called My Special Aflac Duck will reduce distress in children who have been diagnosed with cancer. This multi-center study will involve 20 children, ages 3-10, at each of 8 hospitals and their parent or guardian. There will be a total of 160 participants enrolled nationally.

Study identification

NCT ID
NCT04409301
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Emory University
Other
Enrollment
160 participants

Conditions and interventions

Interventions

Other · Behavioral

Eligibility (public fields only)

Age range
3 Years to 10 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 17, 2020
Primary completion
Oct 23, 2023
Completion
Jan 21, 2024
Last update posted
Feb 19, 2024

2020 – 2024

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Children's of Alabama Birmingham Alabama 35233
Connecticut Children's Medical Center Hartford Connecticut 06106
Comer Children's Hospital Chicago Illinois 60637
Children's Hospital New Orleans New Orleans Louisiana 70118
C.S. Mott Children's Hospital Ann Arbor Michigan 48109
Children's Mercy Kansas City Kansas City Missouri 64108
St. Louis Children's Hospital St Louis Missouri 63110
Children's Hospital of Richmond Richmond Virginia 23219

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Recently updated Pediatric Cancer trials

Other public records listing Pediatric Cancer. Sorted by last update posted; newest first. Not a recommendation.

All Pediatric Cancer trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04409301, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 19, 2024 · Synced Sep 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04409301 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →